REQUEST A DEMO
Total
USD $0.00
Search more companies

Stefanczyk sp. j. (Poland)

Main Activities: Department Stores
Full name: Stefanczyk sp. j. Profile Updated: September 28, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Stefanczyk sp. j is a company operating in the medical and pharmaceutical industry, offering a wide range of medical, pharmaceutical, and cosmetic products, including tablets, capsules, dietary supplements, modified milk, fruit teas, skincare products, and eye care products. The company's focus is on providing high-quality and safe products for the health and well-being of babies and children.

Headquarters
Ul. Leopolda Tyrmanda 4
Lodz; Lodzkie; Postal Code: 93-218

Contact Details: Purchase the Stefanczyk sp. j. report to view the information.

Website: http://www.aptekarosa.pl

Basic Information
Total Employees:
Purchase the Stefanczyk sp. j. report to view the information.
Outstanding Shares:
Purchase the Stefanczyk sp. j. report to view the information.
Financial Auditors:
Purchase the Stefanczyk sp. j. report to view the information.
Incorporation Date:
May 15, 2006
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Rosa Digital
67%
Company Performance
Financial values in the chart are available after Stefanczyk sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
37.05%
Total operating revenue
35.59%
Operating profit (EBIT)
-0.18%
EBITDA
0.92%
Net Profit (Loss) for the Period
16.31%
Total assets
15.56%
Total equity
11.41%
Operating Profit Margin (ROS)
-1.61%
Net Profit Margin
-0.78%
Return on Equity (ROE)
3.07%
Debt to Equity Ratio
-8.36%
Quick Ratio
-0.06%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?